| Name | Title | Contact Details |
|---|---|---|
Kevin Franck |
SVP - Strategic Marketing and New Product Planning | Profile |
David Lucchino |
Co Founder and Chief Executive Officer | Profile |
Michael Jirousek |
Chief Operating Officer | Profile |
Wendy Arnold |
Chief People Officer | Profile |
Eli Lilly and Company is a global pharmaceutical corporation based in Indianapolis, Indiana, with a history of nearly 150 years. Founded in 1876 by Colonel Eli Lilly, the company has grown to become one of the largest pharmaceutical enterprises in the world, employing over 42,900 people as of 2023. Lilly focuses on biomedical research, drug discovery, and manufacturing, with a diverse portfolio that includes treatments for diabetes, oncology, neuroscience, and immunology. Lilly pioneered the first commercially available insulin product in 1923 and continues to innovate with modern offerings like Trulicity and Mounjaro for diabetes management. The company also develops drugs such as Verzenio for breast cancer and Zyprexa for psychiatric disorders. With a strong emphasis on research and development, Lilly is recognized for its commitment to improving drug accessibility and patient care through partnerships with healthcare providers and systems worldwide.
Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families.
GRAIL`s mission is to detect cancer early, when it can be cured.
HyperOmics Farma Inc. is a MontríŠal, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.